We are the one-stop antibody drug development solution company offering antibody drug discovery such as hybridoma, phage display, single B cell, fully human and bispecific antibody technologies, antibody engineering including antibody humanization, antibody development developability assessment and optimization. We are committed to helping our customers to shorten the timeline for biological drugs from development to clinical use with cutting down the R&D costs.